226 related articles for article (PubMed ID: 30041662)
41. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
[TBL] [Abstract][Full Text] [Related]
42. Genomic CDKN2A/2B deletions in adult Ph
Pfeifer H; Raum K; Markovic S; Nowak V; Fey S; Obländer J; Pressler J; Böhm V; Brüggemann M; Wunderle L; Hüttmann A; Wäsch R; Beck J; Stelljes M; Viardot A; Lang F; Hoelzer D; Hofmann WK; Serve H; Weiss C; Goekbuget N; Ottmann OG; Nowak D
Blood; 2018 Mar; 131(13):1464-1475. PubMed ID: 29348129
[TBL] [Abstract][Full Text] [Related]
43. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets.
Walker GJ; Flores JF; Glendening JM; Lin AH; Markl ID; Fountain JW
Genes Chromosomes Cancer; 1998 Jun; 22(2):157-63. PubMed ID: 9598804
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.
Zhang W; Kuang P; Liu T
Ann Med; 2019 Feb; 51(1):28-40. PubMed ID: 30592434
[TBL] [Abstract][Full Text] [Related]
45. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
Faderl S; Estrov Z; Kantarjian HM; Thomas D; Cortes J; Manshouri T; Chan CC; Hays KJ; Pierce S; Albitar M
Cytokines Cell Mol Ther; 1999 Sep; 5(3):159-63. PubMed ID: 10641574
[TBL] [Abstract][Full Text] [Related]
46. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
47. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P
Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763
[TBL] [Abstract][Full Text] [Related]
48. Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
Skalska-Sadowska J; Dawidowska M; Szarzyńska-Zawadzka B; Jarmuż-Szymczak M; Czerwińska-Rybak J; Machowska L; Derwich K
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27759908
[TBL] [Abstract][Full Text] [Related]
49. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M;
J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633
[TBL] [Abstract][Full Text] [Related]
50. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
[TBL] [Abstract][Full Text] [Related]
51. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.
Suzuki H; Zhou X; Yin J; Lei J; Jiang HY; Suzuki Y; Chan T; Hannon GJ; Mergner WJ; Abraham JM
Hum Mol Genet; 1995 Oct; 4(10):1883-7. PubMed ID: 8595411
[TBL] [Abstract][Full Text] [Related]
52. High Positive Correlations between
Drak Alsibai K; Vacher S; Meseure D; Nicolas A; Lae M; Schnitzler A; Chemlali W; Cros J; Longchampt E; Cacheux W; Pignot G; Callens C; Pasmant E; Allory Y; Bieche I
Noncoding RNA; 2019 Aug; 5(3):. PubMed ID: 31438464
[TBL] [Abstract][Full Text] [Related]
53. A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare.
Kumar R; Smeds J; Berggren P; Straume O; Rozell BL; Akslen LA; Hemminki K
Int J Cancer; 2001 Nov; 95(6):388-93. PubMed ID: 11668523
[TBL] [Abstract][Full Text] [Related]
54. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
55. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
56. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.
Takeuchi S; Koike M; Seriu T; Bartram CR; Slater J; Park S; Miyoshi I; Koeffler HP
Leukemia; 1997 Oct; 11(10):1636-40. PubMed ID: 9324282
[TBL] [Abstract][Full Text] [Related]
57. Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A.
Karrman K; Castor A; Behrendtz M; Forestier E; Olsson L; Ehinger M; Biloglav A; Fioretos T; Paulsson K; Johansson B
J Hematol Oncol; 2015 Apr; 8():42. PubMed ID: 25903014
[TBL] [Abstract][Full Text] [Related]
58. The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma.
Prins JB; Williamson KA; Kamp MM; Van Hezik EJ; Van der Kwast TH; Hagemeijer A; Versnel MA
Int J Cancer; 1998 Feb; 75(4):649-53. PubMed ID: 9466670
[TBL] [Abstract][Full Text] [Related]
59. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
[TBL] [Abstract][Full Text] [Related]
60. Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia.
Krieger D; Moericke A; Oschlies I; Zimmermann M; Schrappe M; Reiter A; Burkhardt B
Haematologica; 2010 Jan; 95(1):158-62. PubMed ID: 19586936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
